The cachexia score (CASCO): A new tool for staging cachectic cancer patients

Journal of Cachexia, Sarcopenia and Muscle

Volumn 2, Issue 2, 2011, Pages 87-93

  Argilés, Josep M ^a   López Soriano, Francisco J ^a   Toledo, Míriam ^a   Betancourt, Angelica ^a   Serpe, Roberto ^a,b   Busquets, Sílvia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Institut de Biomedicina de la Universitat de Barcelona ^*  (Italy)

Author keywords

Anorexia; Cachexia; Physical performance; Quality of life; Wasting score; Weight loss

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 2; INTERLEUKIN 6; LACTIC ACID; PREALBUMIN; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL; UREA;

ALBUMIN BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CACHEXIA; CACHEXIA SCORE; CANCER PATIENT; GRIP STRENGTH; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; LACTATE BLOOD LEVEL; LEAN BODY WEIGHT; METABOLIC DISORDER; NUTRITIONAL ASSESSMENT; PHYSICAL PERFORMANCE; PRE CACHEXIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; SCORING SYSTEM; STAGING; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

EID: 84856906459     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1007/s13539-011-0027-5     Document Type: Article

References (36)

1. Springer J, von Haehling S, Anker SD. The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab. 2006; 2: 416-7.
2. Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008; 27: 793-9.
3. Blum D, Omlin A, Fearon K, Baracos V, Radbruch L, Kaasa S, et al. Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer. 2010; 18: 273-9.
4. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010; 29: 154-9.
5. Busquets S, Deans C, Figueras M, Moore-Carrasco R, Lopez-Soriano FJ, Fearon KC, et al. Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clin Nutr. 2007; 26: 614-8.
6. Kalantar-Zadeh K, Kuwae N, Wu DY, Shantouf RS, Fouque D, Anker SD, et al. Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr. 2006; 83: 202-10.
7. Fearon KC, Barber MD, Falconer JS, McMillan DC, Ross JA, Preston T. Pancreatic cancer as a model: inflammatory mediators, acute-phase response, and cancer cachexia. World J Surg. 1999; 23: 584-8.
8. Delano MJ, Moldawer LL. The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract. 2006; 21: 68-81.
9. Faber J, Vos AP, Kegler D, Argiles J, Laviano A, Garssen J, et al. Impaired immune function: an early marker for cancer cachexia. Oncol Rep. 2009; 22: 1403-6.
10. Maddocks M, Byrne A, Johnson CD, Wilson RH, Fearon KC, Wilcock A. Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility study. Support Care Cancer. 2010; 18: 1539-44.
11. Fouladiun M, Korner U, Gunnebo L, Sixt-Ammilon P, Bosaeus I, Lundholm K. Daily physical-rest activities in relation to nutritional state, metabolism, and quality of life in cancer patients with progressive cachexia. Clin Cancer Res. 2007; 13: 6379-85.
12. Laviano A, Meguid MM, Inui A, Muscaritoli M, Rossi-Fanelli F. Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nat Clin Pract Oncol. 2005; 2: 158-65.
13. Granda-Cameron C, DeMille D, Lynch MP, Huntzinger C, Alcorn T, Levicoff J, et al. An interdisciplinary approach to manage cancer cachexia. Clin J Oncol Nurs. 2010; 14: 72-80.
14. Simons JP, Schols AM, Westerterp KR, ten Velde GP, Wouters EF. The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr. 1995; 61: 741-5.
15. Ellis KJ. Human body composition: in vivo methods. Physiol Rev. 2000; 80: 649-80.
16. Plank LD. Dual-energy X-ray absorptiometry and body composition. Curr Opin Clin Nutr Metab Care. 2005; 8: 305-9.
17. Ellegard LH, Ahlen M, Korner U, Lundholm KG, Plank LD, Bosaeus IG. Bioelectric impedance spectroscopy underestimates fat-free mass compared to dual energy X-ray absorptiometry in incurable cancer patients. Eur J Clin Nutr. 2009; 63: 794-801.
18. Araujo JP, Lourenco P, Rocha-Goncalves F, Ferreira A, Bettencourt P. Nutritional markers and prognosis in cardiac cachexia. Int J Cardiol. 2009; 146: 359-63.
19. Argiles JM, Alvarez B, Lopez-Soriano FJ. The metabolic basis of cancer cachexia. Med Res Rev. 1997; 17: 477-98.
20. Pisters PW, Pearlstone DB. Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions. Crit Rev Clin Lab Sci. 1993; 30: 223-72.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9.
22. Mantovani G, Maccio A, Madeddu C, Massa E. Cancer-related cachexia and oxidative stress: beyond current therapeutic options. Expert Rev Anticancer Ther. 2003; 3: 381-92.
23. Barreiro E, de la Puente B, Busquets S, Lopez-Soriano FJ, Gea J, Argiles JM. Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats. FEBS Lett. 2005; 579: 1646-52.
24. Pavlatou MG, Papastamataki M, Apostolakou F, Papassotiriou I, Tentolouris N. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2009; 58: 1657-62.
25. Mantovani G, Maccio A, Madeddu C, Mura L, Gramignano G, Lusso MR, et al. Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med. 2003; 81: 664-73.
26. Nakanishi K. Innate and acquired activation pathways in T cells. Nat Immunol. 2001; 2: 140-2.
27. Mantovani G, Maccio A, Melis G, Mura L, Massa E, Mudu MC. Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine. Int J Cancer. 2000; 86: 842-7.
28. Daly JM, Dudrick SJ, Copeland 3rd EM. Intravenous hyperalimentation. Effect on delayed cutaneous hypersensitivity in cancer patients. Ann Surg. 1980; 192: 587-92.
29. Dahele M, Skipworth RJ, Wall L, Voss A, Preston T, Fearon KC. Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy. J Pain Symptom Manage. 2007; 33: 676-85.
30. Luna-Heredia E, Martin-Pena G, Ruiz-Galiana J. Handgrip dynamometry in healthy adults. Clin Nutr. 2005; 24: 250-8.
31. Brunelli A, Salati M. Preoperative evaluation of lung cancer: predicting the impact of surgery on physiology and quality of life. Curr Opin Pulm Med. 2008; 14: 275-81.
32. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985; 132: 919-23.
33. Wiedenmann B, Malfertheiner P, Friess H, Ritch P, Arseneau J, Mantovani G, et al. A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J Support Oncol. 2008; 6: 18-25.
34. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365-76.
35. Ottery F. Patient-generated subjective global assessment. In: Polisena PMC, editor. The Clinical Guide to Oncology Nutrition. Chicago: The American Dietetic Association; 2000. p. 11-23.
36. von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle. J Cachexia Sarcopenia Muscle. 2010; 1: 7-8.